B

대봉엘에스

078140KOSDAQ

57.0 / 100

Reference Date: 2026-10-23

Financial Score30.5 / 40
News Sentiment12.5 / 25
Momentum4.0 / 20
Disclosure10.0 / 15
AI Analysis: PBR is significantly undervalued vs. peers and the debt ratio is very low with excellent financial health is also solid. Declined 5.7% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Daebong LS, established in 1986, operates across medical beauty and bio sectors, developing safe and effective products aligned with its mission to provide solutions for a healthier, more beautiful life. Key offerings include respiratory treatments, hypertension drugs, and functional cosmetic materials, with consolidated revenue reaching 1,021 billion KRW in 2025, reflecting an 8.6% year-over-year growth.

Number of Employees

138people

Average Salary

54.2M KRW

Score Calculation Basis

Detailed Financial Score

PER
7.53Industry Average 15.006.5Point

Lower than industry avg (good)

PBR
0.44Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE
7.05Industry Average 8.002.5Point

Below industry avg

Debt Ratio
39.82Industry Average 100.006.5Point

Half of industry avg (excellent)

Trend 2023~20258.0 / 10 points
Revenue Growth Rate
2.0 / 3

Avg ▲7.9% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲59.6% (2-year basis)

ROE Trend
3.0 / 4

Avg ROE 5.8% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 6,920Won52-week high 12,85052-week low 6,920
1-month return2.0Point

1m -5.72% (slight drop)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0